Latest Share Chat

Scancell Holdings Share News (SCLP)

Scancell Holdings Information

Buy SCLP Shares
Add SCLP to Watchlist
Add SCLP to Alert

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 9.75

Bid: 9.50

Ask: 10.00

Change: 0.00 (0.00%)

Spread: 0.50 (5.263%)

Open: 9.75

High: 9.75

Low: 9.75

Prev. Close: 9.75

Last checked at -

IN BRIEF: Scancell to focus on cancer vaccine assets amid trial data

Mon, 10th Jul 2023 11:45

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Will focus on lead cancer vaccine assets SCIB1 and Modi-1 following encouraging data from clinical trials. Adds phase two single arm scope trial investigating the safety and tolerability of using SCIB1 in combination with checkpoint inhibitors in patients with advanced melanoma is progressing well and notes a potential pathway for a registration trial. Adds it is fully funded to the second half of 2024 due to its increasing focus on the two clinical assets.

Current stock price: 13.30 pence, up 1.3% on Monday

12-month change: up 4.3%

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

4 Apr 2016 09:31

Scancell Raises Further Funding Through Open Offer (ALLISS)

1 Apr 2016 11:27

CORRECT: Scancell Raises Funds In Placing, Open Offer (ALLISS)

1 Apr 2016 09:06

Scancell Raises Total Of GBP6.1 Million In Placing, Open Offer (ALLISS)

11 Mar 2016 08:51

Scancell skips higher on Swedish research collaboration

(ShareCast News) - Immuno-oncology specialist Scancell has impressed investors with a new research partnership with Sweden's Karolinska Institutet into the role of citrullinated proteins in the treatment of cancer. Both parties have uncovered important roles that citrullinated proteins can play in h

11 Mar 2016 08:01